References
- Jenkinson C., Fitzpatrick R., Brennan C., Bromberg M., Swash M. Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neuron disease: the ALSAQ‐40. J Neurol 1999; 246((Suppl 3))16–21
- Jenkinson C., Fitzpatrick R., Brennan C., Swash M. Evidence for the validity and reliability of the ALS Assessment Questionnaire: The ALSAQ‐40. Amyotroph Lateral Scler Other Motor Neurone Disord 1999; 1: 33–40
- Jenkinson C., Levvy G., Fitzpatrick R., Garratt A. The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ‐40): tests of data quality, score reliability and response rate in a survey of patients. J Neurological Sciences 2000; 180: 94–100
- Fairclough D. Analysing studies with missing data. Assessing Quality of Life in Clinical Trials, Second Edition, P Fayers, R Hays. Oxford University Press, Oxford 2005
- Berzon R. A. Understanding and using health related quality of life instruments within clinical research studies. Quality of Life Assessment in Clinical Trials: Methods and Practice, M. J Staquet, R. D Hays, P. M Fayers. Oxford University Press, Oxford 1998
- Jenkinson C., Fitzpatrick R., Norquist J., Findley L., Hughes K. Cross‐cultural validation of the Parkinson’s Disease Questionnaire: tests of data quality, score reliability, response rate and scaling assumptions in America, Canada, Japan, Italy and Spain. J Clin Epidemiol 2003; 56: 843–7
- Friedman L. M., Furberg C. D., DeMets D. L. Fundamentals of Clinical Trials. Springer, New York 1998
- Jenkinson C., Levvy G., Fitzpatrick R., Garratt A. The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ‐40): tests of data quality, score reliability and response rate in a survey of patients. J Neurol Sciences 2000; 180: 94–100
- Efficace F., Bottomley A., Vanvoorden V., Blazeby J. Methodological issues in assessing health‐related quality of life of colorectal cancer patients in randomized controlled trials. Eur J Cancer 2004; 40: 187–97
- Vercherin P., Gutknecht C., Guillemin F., Ecochard R., Mennen L. ‐I., Mercier M. Non‐reponses aux questionnaires de qualite de vie SF‐36 dans un echantillon de l'etude SU.VI.MAX. Rev Epidemiol Sante Publique 2003; 51: 513–25
- Liu H., Hays R. D., Adams J. L., Chen W. P., Tisuado D., Mangione C. M., et al. Imputation of SF‐12 health status scores for patients with partially missing data. Health Services Research 2005; 40: 905–21
- Fairclough D., Peterson H., Chang V. Why are missing quality of life data a problem in clinical trials of cancer therapy?. Stat Med 1998; 17: 667–77
- Schafer J. L. Analysis of incomplete multivariate data. Chapman and Hall, London 1997
- Little R. J. A., Rubin D. B. The analysis of social science data with missing values. Modern Methods of Data Analysis, S Fox, J. S Long. Sage, Newbury Park, CA 1990
- Jenkinson C., Heffernan C., Doll H., Fitzpatrick R. The Parkinson’s Disease Questionnaire (PDQ‐39): evidence for a method of imputing missing data. Age and Ageing 2006; 35: 497–502
- Jenkinson C., Norquist J., Fitzpatrick R. Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ‐40 and ALSAQ‐5). Journal of Neurology, Neurosurgery and Psychiatry 2003; 74: 242–5
- Jenkinson C., Peto V., Jones G., Fitzpatrick R. Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ‐40). Clinical Rehabilitation 2003; 17: 380–5
- Jenkinson C., Fitzpatrick R., Swash M., Levvy G. ALSAQ User Manual. Health Services Research Unit, Department of Public Health, University of Oxford, Oxford 2001
- Putter H., Marijnen C., Kranenbarg E., van de Velde C., Stiggelbout A. Missing forms and dropout in the TME quality of life substudy. Quality of Life Research 2005; 14: 857–65